Krisztina Hagymasi
Overview
Explore the profile of Krisztina Hagymasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boglarka Z, Zsombor Z, Ronaszeki A, Egresi A, Stollmayer R, Himsel M, et al.
Diagnostics (Basel)
. 2025 Jan;
15(2).
PMID: 39857087
we evaluated regression models based on quantitative ultrasound (QUS) parameters and compared them with a vendor-provided method for calculating the ultrasound fat fraction (USFF) in metabolic dysfunction-associated steatotic liver disease...
2.
Vereczkei Z, Szakacs Z, Peresztegi M, Lemes K, Hagymasi K, Dako S, et al.
BMJ Open
. 2024 Oct;
14(10):e084365.
PMID: 39384235
Introduction: Coeliac disease (CD) affects 1% of the population worldwide. The only available evidence-based treatment is a strict gluten-free diet (GFD), which can readily lead to weight gain and unfavourable...
3.
Egresi A, Blazovics A, Lengyel G, Toth A, Csongrady B, Jakab Z, et al.
Diagnostics (Basel)
. 2024 Sep;
14(17).
PMID: 39272729
Hepatic fibrosis with various origins can be estimated non-invasively by using certain biomarkers and imaging-based measurements. The aim of our study was to examine redox homeostasis biomarkers and liver stiffness...
4.
Kokas B, Krizsany G, Pekli D, Meltzer A, Bardos D, Rozsa B, et al.
Orv Hetil
. 2024 Sep;
165(36):1433-1439.
PMID: 39244743
No abstract available.
5.
Hoferica J, Borbely R, Aghdam A, Szalai E, Zolcsak A, Veres D, et al.
Sci Rep
. 2024 Jul;
14(1):16723.
PMID: 39030187
Chronic liver diseases (CLD) affect 1.5 billion patients worldwide, with dramatically increasing incidence in recent decades. It has been hypothesized that the chronic hyperinflammation associated with CLD may increase the...
6.
Floria D, Obeidat M, Kavasi S, Teutsch B, Veres D, Hagymasi K, et al.
Sci Rep
. 2024 May;
14(1):11956.
PMID: 38796481
The Montreal consensus recognizes chronic cough as an extra-esophageal manifestation of gastroesophageal reflux disease. We performed a meta-analysis to assess the effects of acid-suppressive medications in adults with non-specific chronic...
7.
Tari E, Gagyi E, Rancz A, Veres D, Vancsa S, Hegyi P, et al.
Sci Rep
. 2024 Mar;
14(1):7341.
PMID: 38538734
Endoscopic Retrograde Cholangiopancreatography (ERCP) is the primary therapeutic procedure for pancreaticobiliary disorders, and studies highlighted the impact of papilla anatomy on its efficacy and safety. Our objective was to quantify...
8.
Kaposi P, Zsombor Z, Ronaszeki A, Budai B, Csongrady B, Stollmayer R, et al.
Diagnostics (Basel)
. 2023 Nov;
13(21).
PMID: 37958249
We aimed to develop a non-linear regression model that could predict the fat fraction of the liver (UEFF), similar to magnetic resonance imaging proton density fat fraction (MRI-PDFF), based on...
9.
Mako R, Egresi A, Blazovics A, Oszlanyi R, Hagymasi K
Orv Hetil
. 2023 Aug;
164(33):1294-1299.
PMID: 37598365
Today, non-alcoholic fatty liver disease is the most common chronic liver disease, yet there is no clearly accepted effective therapy. What is certain is that the number of people suffering...
10.
Dracz B, Muller V, Takacs I, Hagymasi K, Dinya E, Miheller P, et al.
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371636
Hypocalcemia is a common condition in liver cirrhosis and is associated with the severity of SARS-CoV-2 infection. However, there is a lack of data demonstrating the prognostic value of hypocalcemia...